SIG BROKERAGE, LP
Broker-DealerPosition in NBIX — Neurocrine Biosciences Inc
CIK 1094429
BALA CYNWYD, PA
Position in NBIX
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$441,237
-$337,609 QoQ
Shares Held
2,618
-55.7% QoQ
Ownership
0.003%
of shares outstanding
% of Portfolio
0.08%
of 13F equity value
Holder Rank
#492
of 768 holders
Holding Since
Mar 2026
2 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in NBIX Over Time
Shares Held
Position Value (USD)
Derivatives in NBIX
reported options exposure · as of Jun 30, 2026CallValue
$0
CallShares
0
PutValue
$1,668,546
PutShares
9,900
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026SIG BROKERAGE, LP holds $7,382,863 across 5 Drug Manufacturers - Specialty & Generic names. NBIX ranks #4 (6.0% of the industry book) .
All Filings in NBIX
Export CSV
4 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $441,237 | 2,618 | Shares | Sole | 2026-08-14 | |
| 2026-06-30 | $1,668,546 | 9,900 | Put | Sole | 2026-08-14 | |
| 2026-03-31 | $778,846 | 5,912 | Shares | Sole | 2026-05-15 | |
| 2026-03-31 | $1,304,226 | 9,900 | Put | Sole | 2026-05-15 | |
| No filing history on record for this holder in this stock. | ||||||